Bakgrunn og aktiviteter
Fagfelt / arbeidsområde
Underviser ved radiografutdanninga ved campus Trondheim, og har ansvar for Master i medisinsk MR-avbildning og Videreutdanning i MR. Forskning innen MRS og MRI, herunder MR av muskel/skjelett og revmatisk sykdom.
Kompetanse
Kjemiker, med doktorgrad i medisinsk teknologi fra NTNU. Lang erfaring med MR-spektroskopiske analyser av væsker og vevsprøver, i hovedsak mot kreft og andre medisinske problemstillinger.
Bakgrunn
Arbeidserfaring:
2016 - Førsteamanuensis ved NTNU, Fakultet for medisin og helsevitenskap
2014 - 2015: Førsteamanuensis ved HiST, Fakultet for helse og sosialvitenskap
2011 - 2014: Førsteamanuensis ved HiST, Avdeling for teknologi
2005 - 2011: Postdoktor, forsker og koordinator ved NTNU, Det medisinske fakultet
2003 - 2004: Stipendiat ved St. Olavs Hospital
1997 - 2003: Forsker og stipendiat ved SINTEF Unimed
Utdanning:
2004: PhD Medisinsk teknologi (NTNU)
1996: MsC i kjemi (NTNU)
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
Tidsskriftspublikasjoner
- (2017) Quantifying bone marrow inflammatory edema in the spine and sacroiliac joints with thresholding. BMC Musculoskeletal Disorders. vol. 18 (1).
- (2016) Impact of freezing delay time on tissue samples for metabolomic studies. Frontiers in Oncology. vol. 6.
- (2016) High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancer. Radiotherapy and Oncology. vol. 118 (2).
- (2015) Er forelesninga effektiv, interessant og meningsfull? - Oppfatninger om og betydningen av forelesninger som undervisningsform. UNIPED. vol. 38 (4).
- (2014) Interplay of choline metabolites and genes in patient-derived breast cancer xenografts. Breast Cancer Research. vol. 16 (1).
- (2013) Feasibility of MR Metabolomics for Immediate Analysis of Resection Margins during Breast Cancer Surgery. PLoS ONE. vol. 8 (4).
- (2013) Metabolic changes in psoriatic skin under topical corticosteroid treatment. BMC Dermatology. vol. 13.
- (2012) Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy. BMC Cancer. vol. 12.
- (2012) Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling. NMR in Biomedicine. vol. 25 (2).
- (2012) Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers. NMR in Biomedicine. vol. 25 (11).
- (2011) In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response. Magnetic Resonance Materials in Physics, Biology and Medicine. vol. 24 (6).
- (2011) HR MAS MR Spectroscopy in Metabolic Characterization of Cancer. Current Topics in Medicinal Chemistry. vol. 11 (1).
- (2010) Magnetic Resonance Metabolomics of Intact Tissue: A Biotechnological Tool in Cancer Diagnostics and Treatment Evaluation. Cancer Research. vol. 70 (17).
- (2010) Merging transcriptomics and metabolomics - advances in breast cancer profiling. BMC Cancer. vol. 10.
- (2010) Transcriptomics meets metabolomics - correlating snapshots of breast cancer metabolism. European Journal of Cancer. vol. 8 (5).
- (2010) Alignment of high resolution magic angle spinning magnetic resonance spectra using warping methods. Analytica Chimica Acta. vol. 683 (1).
- (2010) Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics. Journal of Proteome Research. vol. 9 (2).
- (2010) Functional and molecular MR for breast cancer characterization. European Journal of Cancer. vol. 8 (5).
- (2010) Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer. vol. 10.
- (2010) Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR in Biomedicine. vol. 23 (4).